Xyntha Solofuse 1000 Unit (Moroctocog Alfa POWDER FOR SOLUTION) 1000 UNIT

XYNTHA SOLOFUSE 1000 Unit is a powder for solution used for intravenous administration. It contains moroctocog alfa, a recombinant coagulation factor VIII. This product is designed to help manage bleeding episodes in patients with hemophilia A.

Strength

1000 UNIT

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XYNTHA SOLOFUSE 1000 Unit is primarily used for the treatment and prevention of bleeding episodes in patients with hemophilia A. Hemophilia A is a genetic disorder that affects the body's ability to clot blood properly. This medication works by replacing the missing clotting factor VIII, which helps to control bleeding. It is often used in situations where bleeding needs to be managed quickly and effectively.

Side Effects

Common effects of XYNTHA SOLOFUSE 1000 Unit may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some users may also experience mild allergic reactions. These effects are generally mild and temporary. If severe reactions occur, medical attention should be sought immediately.

Precautions & Warnings

XYNTHA SOLOFUSE 1000 Unit should be handled with care and stored according to the manufacturer's instructions. It is important to use this medication under the supervision of a healthcare professional. Patients with known allergies to moroctocog alfa or any of the excipients should avoid using this product. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

XYNTHA SOLOFUSE 1000 Unit may interact with certain medications, including those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect blood clotting should be avoided unless approved by a healthcare professional.

Frequently Asked Questions

XYNTHA SOLOFUSE 1000 Unit is used to manage bleeding episodes in patients with hemophilia A.

XYNTHA SOLOFUSE 1000 Unit is administered intravenously after reconstituting the powder with the provided solvent.

Common side effects may include localized reactions at the injection site, such as redness, swelling, or discomfort.

It is important to consult a healthcare provider before using XYNTHA SOLOFUSE 1000 Unit with other medications.

XYNTHA SOLOFUSE 1000 Unit should be stored according to the manufacturer's instructions to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.